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Abstract 
The aim of this analysis was to examine mean differences of the speed of recovery (days) from COVID-19 
infection by case-patients based in three different districts in Mpumalanga province. A sample of 5723 case-
patients distributed across three districts in the province; namely Gert Sibande, Ehlanzeni and Nkangala. Using 
the date at which the result confirming positivity for each case was received and the date at which discharge 
occurred, the DATEDIF() function in Microsoft Excel was used to calculate the speed of recovery, measured by 
number of days. The speed (time) from infection to recovery was thus measured as the number of days from first 
positive to first negative SARSCoV-2 PCR test result. Data was processed in Statistical Package for Social 
Sciences (SPSS) version 21 for windows prior to conducting statistical analysis. The mean differences in the 
speed of recovery across the three districts were analysed using the mean comparison Analysis of Variance 
(ANOVA) technique. Mean and standard deviation (mean ± sd) statistics show that cases in Gert Sibande had 
the quickest average recovery speed of 16.43 ± 7.14 days, followed by Ehlanzeni with 17.07 ± 7.18 days, while 
cases in Nkangala had the marginally longest recovery time of 17.09 ± 7.56 days at 95% confidence interval. 
The F (2, 531.96) statistic (= 4.297; p < 0.05) and the Tukey HSD post-hoc results indicate significant differences in 
the speed of recovery by case-patients in the three districts. The mean statistics results demonstrate that the mean 
recovery speed of case-patients in Gert Sibande differed significantly from average recovery speeds of case-
patients in Ehlanzeni and Nkangala. 
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1. Introduction  
Human coronaviruses have become common throughout the world. Many different coronaviruses are identified 
in animals, while merely a small number of them can cause disease in human beings (Department of Health, 
2020). The coronaviruses are basically a large family of viruses which may cause respiratory infections ranging 
from common colds to more severe diseases such as Middle East Respiratory Syndrome (MERS) and Severe 
Acute Respiratory Syndrome (SARS). The global pandemic of coronavirus disease 2019 (COVID-19) was first 
reported on 31 December 2019 by the World Health Organization (WHO) country office following a cluster of 
pneumonia cases in Wuhan City, Hubei Province of China (National Institute of Communicable Diseases, 2020).  
 
SARS-CoV-2 has been confirmed as the causative virus of COVID-19, which has rapidly become a global 
pandemic continuing to spread across countries in the world. Most of case-patients initially identified were 
dealers and vendors at a seafood, poultry and live wildlife market in China (WHO, 2020). In line with the global 
statistics, people who are most at higher risk are the elderly, individuals with co-morbidities and healthcare 
workers (Department of Health, 2020). The spread of the disease is believed to happen primarily via respiratory 
droplets produced when an infected person coughs or sneezes, similar to how influenza and other respiratory 
pathogens spread. Thus, the majority of cases have occurred in people with close physical contact to cases and 
healthcare workers proving healthcare to patients with COVID-19 (National Institute of Communicable 
Diseases, 2020). 
Treatment of COVID-19 is mainly supportive in form provision of oxygen for patients with some shortness of 
breath, coupled with other associated symptoms like fever, dry cough and sore throat, Human antibiotics do not 
treat viral infections, but such antibiotics may be required if a bacterial secondary infection develops (Lechien, et 
al., 2019). In pursuit of efforts to curb the rapid spread of the disease, on 1st April 2020, the Ministry of Health in 
South Africa launched 60 new mobile laboratories to boost the country’s capacity to test for COVID-19. 
Sampling and testing units, procured by the National Health Laboratory Service (NHLS) have been deployed 
nationwide to all priority districts and metros. The United States (US) President’s Emergency Plan for AIDS 
Relief (PEPFAR)-funded District Support Partners (DSPs) is supporting all the provinces in the programme 
(Department of Health, 2020).  
 
1.1. Research Objective  
 To determine mean differences in the speed of recovery (days) from COVID-19 infection by case-
patients based in three different districts in Mpumalanga province.   
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1.2. Research Question  
 Are there mean differences in the speed of recovery (days) from COVID-19 infection by case-patients 
based in three different districts in Mpumalanga province?   
 
1.3. Research Hypothesis   
 There are mean differences in the speed of recovery (days) from COVID-19 infection by case-patients 
based in three different districts in Mpumalanga province.  
 
1.4. Significance of the Study  
The results from this analysis are expected to contribute greatly towards developing mechanisms that can be 
deemed relevant to help curtail the geographical spread of the disease in the province. From a monitoring 
standpoint, findings are expected to provide insights on the key areas where mapping and tracking would need to 
be continuously conducted using dashboards and geographical information systems (GIS). 
    
2. Materials and Methods  
2.1. Design 
A descriptive research design was applied in the analysis. The categorical factor were the districts in the 
province, while and dependent variable was recovery speed measured in number of days.  
2.2. Population and Sample 
The population for the study was patients who got infected and first tested positive from the first SARS CoV-2 
PCR test and later tested negative to SARS-CoV-2 PCR test after a certain period. The sample consists of 5 723 
clinically confirmed recovered cases as at 21 July 2020.        
 
2.3. Data 
The secondary dataset used in the analysis was obtained from Mpumalanga Department of Health (MDoH). Data 
cleaning and processing was initially conducted in Excel and Statistical Package for Social Sciences (SPSS) 
prior to conducting statistical analysis. The variable “recovery speed (days)” was calculated by inserting the date 
at which the result confirming positivity was received and the date discharge occurred into the DATEDIF() 
function in Excel. Thus, time from infection to recovery is measured as the number of days from first positive to 
first negative SARSCoV-2 PCR test result.  
 
 
2.4. Treatment  
The sample was categorised into three districts; namely Gert Sibande, Ehlanzeni and Nkangala.  
 
2.5. Statistical Analysis Technique 
The univariate one-way Analysis of Variance (ANOVA) statistical technique was applied to examine mean 
differences in the recovery speed (days) from COVID-19 infection; based on the following function.  
   Cx,zF ijij                   (1) 
where F represents the function which transforms x into z; with z denoting recovery speed (days) of the ith case 
in district j; x represents the ith positivity and discharge record applied to district j; and C denotes a positive 
scalar, which overall further reduces to:    
 
ikijjjij εDRS  ;               (2) 
where RS is the recovery speed (days) of the ith case in district j; D represents the district on the ith case in district 
j; and j  
represents the average speed of recovery attributed to a particular district. 
 
Descriptive statistics were computed to analyse the means, standard deviation and standard error estimates; while 
the ANOVA Tukey HSD post hoc test was used to examine whether any significant differences existed between 
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3. Results and Analysis  
This section comprises of two sub sections namely 3.1 which presented descriptive statistics for the study 
focusing on measures of central tendency and dispersion. In Section 3.2, Analysis of Variance (ANOVA) was 
discussed in somewhat detail. 
 
3.1. Descriptive Statistics  
Table 1: Descriptive Statistics 
Recovery speed (days)   












Gert Sibande 1794 16.43 7.139 .169 16.10 16.76 4 88 
Ehlanzeni 1258 17.07 7.177 .202 16.68 17.47 1 69 
Nkangala 2671 17.09 7.562 .146 16.80 17.38 3 86 
Total 5723 16.88 7.353 .097 16.69 17.07 1 88 
 
Table 1 presents descriptive statistics for the speed (days) at which cases which had COVID-19 infection 
recovered from the disease across the three districts in Mpumalanga province, namely Gert Sibande, Ehlanzeni 
and Nkangala. From entire sample of five thousand seven hundred and twenty-three (n = 5 723) COVID-19 
infected patients, the largest proportion of 47% (n = 2 671) of the cases were in Nkangala, followed by 31% (n = 
1 794) of the cases in Gert Sibande, while the least proportion of 22% (n = 1 258) of the cases were in Ehlanzeni.  
 
Based on mean and standard deviation (mean ± sd) statistics, district comparison of the recovery rate from 
COVID-19 infection statistics show that cases in Gert Sibande had the quickest average recovery speed of 16.43 
± 7.14 days, followed by patients in Ehlanzeni with an average recovery speed of 17.07 ± 7.18 days while 
patients in Nkangala had the marginally longest recovery rate of 17.09 ± 7.56 days at 95% confidence interval. 
At provincial level, the recovery speed of patients from the infection stood at 16.88 ± 7.35 days.  
 
3.2. ANOVA Statistics 
Table 2: Test of Homogeneity of Variances 
Recovery speed (days)   
Levene Statistic df1 df2 Sig. 
2.496 2 5720 .083 
The Levene statistics (F-statistic = 2.496; p < 0.05), which tests for the assumption of homogeneity of variance 
show evidence of existence of a significant difference between the two districts’ variances. Therefore, the 
assumption of homogeneity of variance was not satisfied.  
 
Table 3: ANOVA 
Recovery speed (days)   
 Sum of Squares df Mean Square F Sig. 
Between Groups 531.960 2 265.980 4.927 .007 
Within Groups 308809.176 5720 53.988   
Total 309341.136 5722    
 
Table 3 ANOVA results indicate that statistical evidence that mean recovery speed (days) from COVID-19 
infection differed significantly among the three districts (F (2, 531) statistic (= 4.927; p < 0.05) at 5% level of 
significance). To detect which of the three districts mean recovery speeds differed significantly from one 
another; the Tukey HSD post hoc test was conducted (Table 3). In light of the number of comparisons that were 
made, the Tukey post hoc approach was applied because of its power to control for alpha inflation.  
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Table 4: Multiple Comparisons 
Dependent Variable:   Recovery speed (days)   
Tukey HSD   
(I) District (J) District 
Mean 
Difference (I-J) 
Std. Error Sig. 
95% Confidence Interval 
Lower Bound Upper Bound 
Gert Sibande 
Ehlanzeni -.646* .270 .044 -1.28 -.01 
Nkangala -.662* .224 .009 -1.19 -.14 
Ehlanzeni 
Gert Sibande .646* .270 .044 .01 1.28 
Nkangala -.016 .251 .998 -.61 .57 
Nkangala 
Gert Sibande .662* .224 .009 .14 1.19 
Ehlanzeni .016 .251 .998 -.57 .61 
*. The mean difference is significant at the 0.05 level. 
 
The Tukey post hoc tests results show that the mean recovery speed of case-patients in Gert Sibande differed 
significantly from average recovery speeds of case-patients in Ehlanzeni and Nkangala. No significant 
differences existed between mean recovery speed of case-patients in Ehlanzeni and those in Nkangala. 
Table 5: Homogeneous Subsets 
Recovery speed (days) 
Tukey HSDa,b   
District N Subset for alpha = 0.05 
1 2 
Gert Sibande 1794 16.43  
Ehlanzeni 1258  17.07 
Nkangala 2671  17.09 
Sig.  1.000 .998 
Means for groups in homogeneous subsets are displayed. 
a. Uses Harmonic Mean Sample Size = 1737.400. 
b. Group sizes are unequal. The harmonic mean of the group sizes is used. Type I error levels are not 
guaranteed. 
 
Homogenous subsets results provide as an alternative approach considered as being more appropriate for 
computing and displaying the post hoc tests particularly when group sizes are objectively different. The null 
hypothesis of the subsets establishes that groups computed in the same subset are not significantly different. 
Results presented in Table 5 indicate significant differences in average speed of recovery case patients in 
Ehlanzeni and Nkangala districts, while there are no statistically significant differences in the speed of recovery 
exist among case-patients in Ehlanzeni and Nkangala.  
 
4. Recommendations 
Infection prevention and control (IPC) efforts might need to be strengthened in Nkangala where recovery speeds 
of case-patients in that district are relatively longer than in other districts. The provincial Department of Health 
should provide assistance to the district support teams (DSTs) aimed at upscaling interventions that prevent the 
spread of infections during healthcare service delivery in facilities like hospitals, outpatient clinics, dialysis 
centers and long-term care facilities. Such measures may include rapid identification of suspect cases, rapid 
screening or triage at initial healthcare facility encounter and rapid implementation of source control, limiting the 
entry of healthcare workers and visitors with suspected or confirmed COVID-19, cohort patients with suspected 
or confirmed COVID-19 separately, and safe clinical management.  
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